Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/04/13 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 02/14/13 | UPLOAD | SEC-generated letter |
|
2 | |
| 02/07/13 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
110 | |
| 02/04/13 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 01/24/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/22/13 | 8-K | Current report filing |
|
6 | |
| 01/16/13 | 8-K | Current report filing |
|
6 | |
| 01/14/13 | 8-K | Current report filing |
|
4 | |
| 01/02/13 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
6 |
| 12/31/12 | 8-K | Current report filing |
|
5 |
